Skip to content

OPTIMER PHARMACEUTICALS INC

Delisted

CIK 1142576fmd_1DPE5WCGZ2XM8J3ZPAS0YWF1ZAManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2013, 14 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012
Total revenues11145102
Cost of revenue––25
Gross profit––14396
Research and development34334345
Selling, general and administrative91881112
Operating income(43)(49)6(91)
Other non-operating income (expense)0000
Income before taxes–(47)8(37)
Income tax expense––0(0)
Net income from continuing operations––8(36)
Net income(42)(49)6(37)
Net income to common shareholders(42)(47)8(37)